Benzinga | Mar 10, 2021 04:12PM EST

Harpoon Therapeutics Q4 EPS $(0.45) Beats $(0.54) Estimate, Sales $7.49M Beat $5.18M Estimate

Harpoon Therapeutics (NASDAQ:HARP) reported quarterly losses of $(0.45) per share which beat the analyst consensus estimate of $(0.54) by 16.67 percent. This is a 22.41 percent increase over losses of $(0.58) per share from the same period last year. The company reported quarterly sales of $7.49 million which beat the analyst consensus estimate of $5.18 million by 44.63 percent. This is a 235.36 percent increase over sales of $2.23 million the same period last year.